Blog
RSS FeedPosted by Michael Wonder on 10 Nov 2021
Merck and Ridgeback announce Japanese Government to purchase 1.6 million courses of molnupiravir, an investigational oral COVID-19 anti-viral medicine, upon authorisation or approval
10 November 2021 - Merck and Ridgeback Biotherapeutics today announced that the Japanese government will purchase, upon authorization or approval, approximately ...
Posted by Michael Wonder on 09 Nov 2021
WHO warns of massive syringe shortfall in 2022
10 November 2021 - There could be a shortage of up to two billion syringes in 2022 with billions more than ...
Posted by Michael Wonder on 09 Nov 2021
Merck and Ridgeback announce U.S. Government to purchase 1.4 million additional courses of molnupiravir, an investigational oral anti-viral medicine, for the treatment of mild to moderate COVID-19 in at risk adults
9 November 2021 - Merck and Ridgeback Biotherapeutics today announced that the United States Government will exercise two of its options ...
Posted by Michael Wonder on 07 Nov 2021
COVID-19: PHARMAC confident with growing stock of drugs to treat virus
7 November 2021 - PHARMAC is growing increasingly confident it is getting close to having enough of the drugs needed to ...
Posted by Michael Wonder on 06 Nov 2021
Pharmaceutical Benefits Scheme continued dispensing arrangements
5 November 2021 - The Australian Government has extended the Continued Dispensing emergency arrangements until 30 June 2022, when they ...
Posted by Michael Wonder on 29 Oct 2021
PBS arrangements for tocilizumab shortage – 1 November 2021
29 October 2021 - In response to the shortages of multiple presentations of tocilizumab (Actemra) products, the PBAC has recommended temporary ...
Posted by Michael Wonder on 21 Oct 2021
Delivery of Novavax vaccine may be delayed in Australia due to reported manufacturing issues
21 October 2021 - Australians may not get access to the Novavax vaccine this year with reports of manufacturing problems causing ...
Posted by Michael Wonder on 21 Oct 2021
Tasmania's Pharmacy Guild wants antiviral COVID-19 pills available in all pharmacies
20 October 2021 - Tasmania has a stockpile of two different antiviral pill products which are sitting in the Royal ...
Posted by Michael Wonder on 18 Oct 2021
Australia secures additional COVID-19 treatments
17 October 2021 - The Australian Government has secured access to two additional COVID-19 treatments to support the National Plan to ...
Posted by Michael Wonder on 14 Oct 2021
Pharmacists opt out of third shot as doses of vaccine set to expire
14 October 2021 - The rollout of third doses of the COVID-19 vaccine to thousands of immunocompromised people has been ...
Posted by Michael Wonder on 12 Oct 2021
When is the Novavax vaccine coming to Australia? Will it be used for booster shots?
13 October 2021 - Australia's vaccination rate is galloping towards 85 per cent, and more than six in 10 Australians ...
Posted by Michael Wonder on 10 Oct 2021
PHARMAC negotiates deal for molnupiravir to treat COVID-19
11 October 2021 - PHARMAC has negotiated an agreement with supplier MSD to purchase the antiviral molnupiravir. ...
Posted by Michael Wonder on 07 Oct 2021
Joint statement: supply allocations of intravenous tocilizumab (Actemra) during serious shortage
7 October 2021 - Roche, the sponsor of tocilizumab (Actemra), notified the TGA of shortages of multiple presentations of tocilizumab ...
Posted by Michael Wonder on 06 Oct 2021
Australia secures additional supplies of sotrovimab
4 October 2021 - The Australian Government has increased supplies of the promising COVID-19 treatment sotrovimab with over 15,000 additional doses ...
Posted by Michael Wonder on 30 Sep 2021
Medicines industry continues to protect Australians from medicine shortages
30 September 2021 - ACCC extends approval for ongoing collaboration ...